SQZ Biotechnologies Co. (SQZ) NEW YORK STOCK EXCHANGE INC.

$8.15 0.24 (3.03%)

Market Cap: $228.74M

As of 01/14/22 04:00 PM EST. Market closed.

(SQZ)

SQZ Biotechnologies Co. (SQZ) NEW YORK STOCK EXCHANGE INC.

$8.15 0.24 (3.03%)

Market Cap: $228.74M

As of 01/14/22 04:00 PM EST. Market closed.

SQZ Biotechnologies is a clinical-stage biotechnology company developing transformative cell therapies for patients with cancer, infectious diseases, and other serious conditions. Using its proprietary technology, SQZ Biotechnologies offers the unique ability to deliver multiple materials into many patient cell types to engineer what SQZ Biotechnologies believes can be an unprecedented range of ... read more

SQZ Biotechnologies is a clinical-stage biotechnology company developing transformative cell therapies for patients with cancer, infectious diseases, and other serious conditions. Using its proprietary technology, SQZ Biotechnologies offers the unique ability to deliver multiple materials into many patient cell types to engineer what SQZ Biotechnologies believes can be an unprecedented range of potential therapeutics for a variety of diseases. SQZ Biotechnologies has the potential to create well-tolerated cell therapies that can provide therapeutic benefit for patients and to improve the patient experience over existing cell therapy approaches. With accelerated production timelines under 24 hours and the opportunity to eliminate preconditioning and lengthy hospital stays, its goal is to use the SQZ approach to establish a new paradigm for cell therapies. The Company's first therapeutic applications aim to leverage the potential to generate target-specific immune responses, both in activation for the treatment of solid tumors and immune tolerance for the treatment of unwanted immune reactions and autoimmune diseases. read less

COMPANY PROFILE
Sector
Manufacturing
Industry
Biological Product (except Diagnostic) Manufacturing
URL
Address
.
Sector
Manufacturing
Industry
Biological Product (except Diagnostic) Manufacturing
Address
.
KEY STATS
Open
$7.90
Previous Close
$7.91
Days Range
$7.53 - $8.34
52 week range
$7.53 - $29.45
Volume
91,253
Avg. Volume (30 days)
80,663
Market Cap
$228.74M
Dividend Yield
0.00%
P/E
-
Shares Outstanding
28,066,795
Open
$7.90
Previous Close
$7.91
Days Range
$7.53 - $8.34
52 week range
$7.53 - $29.45
Volume
91,253
Avg. Volume (30 days)
80,663
Market Cap
$228.74M
Dividend Yield
0.00%
P/E
-
Shares Outstanding
28,066,795

Open in: SeekingAlpha Yahoo Finance Fidelity MorningStar

Open in: SeekingAlpha Yahoo Finance Fidelity MorningStar

INSIDER TRANSACTIONS FOR SQZ BIOTECHNOLOGIES CO
Owner Relationship Date Transaction Cost # Shares Value($) Total Shares Form 4
Sharei Armon President and CEO Jan 12, 2022 Option Exercise $1.81 13,000 23,530 285,448 Jan 13, 2022, 05:15 PM
Sharei Armon President and CEO Dec 31, 2021 Option Exercise $7.59 1,686 12,798 272,448 Jan 04, 2022, 05:15 PM
Knopf Lawrence J General Counsel Dec 31, 2021 Option Exercise $7.59 454 3,446 454 Jan 04, 2022, 05:15 PM
SCHULMAN AMY W Director Dec 22, 2021 Option Exercise $3.52 24,130 84,823 214,814 Dec 23, 2021, 05:15 PM
Sharei Armon President and CEO Dec 22, 2021 Option Exercise $1.81 11,049 19,999 270,762 Dec 22, 2021, 05:15 PM
SCHULMAN AMY W Director Dec 13, 2021 Buy $10.91 3,700 40,367 1,850 Dec 15, 2021, 05:15 PM
Sharei Armon President and CEO Feb 27, 2021 Option Exercise $1.81 8,000 14,480 259,713 Mar 02, 2021, 05:32 PM
Sharei Armon President and CEO Jan 08, 2021 Option Exercise $1.81 2,500 4,525 251,713 Jan 12, 2021, 04:30 PM
Temasek Holdings (Private) Ltd 10% Owner Nov 03, 2020 Buy $16.00 625,000 10,000,000 2,513,924 Nov 05, 2020, 06:08 PM
AMERICAN INTERNATIONAL GROUP INC 10% Owner Nov 03, 2020 Buy $16.00 625,000 10,000,000 625,000 Nov 04, 2020, 04:49 PM
SCHULMAN AMY W Director Nov 03, 2020 Buy $16.00 250,000 4,000,000 2,549,306 Nov 03, 2020, 08:00 PM
Polaris Management Co. VII, L.L.C. 10% Owner Nov 03, 2020 Buy $16.00 250,000 4,000,000 2,549,306 Nov 03, 2020, 08:00 PM
Invus Public Equities, L.P. 10% Owner Nov 03, 2020 Buy $16.00 465,000 7,440,000 1,606,308 Nov 03, 2020, 08:00 PM
AMERICAN INTERNATIONAL GROUP INC 10% Owner Oct 30, 2020 Buy $16.00 625,000 10,000,000 625,000 Nov 02, 2020, 04:34 PM
Load More Insider Transactions
Buy Sale Option Exercise
Owner Relationship Date Value($)
Sharei Armon President and CEO 01/12/2022 23,530
Sharei Armon President and CEO 12/31/2021 12,798
Knopf Lawrence J General Counsel 12/31/2021 3,446
SCHULMAN AMY W Director 12/22/2021 84,823
Sharei Armon President and CEO 12/22/2021 19,999
SCHULMAN AMY W Director 12/13/2021 40,367
Sharei Armon President and CEO 02/27/2021 14,480
Sharei Armon President and CEO 01/08/2021 4,525
Temasek Holdings (Private) Ltd 10% Owner 11/03/2020 10,000,000
AMERICAN INTERNATIONAL GROUP INC 10% Owner 11/03/2020 10,000,000
SCHULMAN AMY W Director 11/03/2020 4,000,000
Polaris Management Co. VII, L.L.C. 10% Owner 11/03/2020 4,000,000
Invus Public Equities, L.P. 10% Owner 11/03/2020 7,440,000
AMERICAN INTERNATIONAL GROUP INC 10% Owner 10/30/2020 10,000,000
Load More Insider Transactions
CHANGE IN SHARES OUTSTANDING
STOCK BUYBACKS
Period of Report
Previous Period
% Change in Shares
10-K/10-Q Filings
Quarter
09/30/2021
06/30/2021
1.18%
1Q
09/30/2021
03/31/2021
4.41%
2Q

Period of Report: 09/30/2021

10-K/10-Q Filings: View

Previous Period
% Change in Shares
Quarter
06/30/2021
1.18%
1Q
03/31/2021
4.41%
2Q